Make Informed Investment Decisions with Affordable Access to Experts
Freedom of Information Act Request
To see if we can get the specific DOJ requests to Pharma companies on drug pricing. These investigations have been confirmed in 10q filings.Ticker(s): MRK, VRX, LLY
The breadth of these investigations and the legal angle the government is taking are important to understand when evaluating the potential ramifications on the industry. The comments around drug pricing have dominated headlines, and more details and specifics are important to understanding what is going on. The government would not confirm the existence of these inquires to the WSJ, but will have to disclose something it under the FOIA requirements. Investors know the investigation exists because of SEC disclosure requirements.
WSJ article: http://www.wsj.com/articles/lilly-merck-receive-inquiries-from-justice-dept-over-drug-pricing-144682...
Government Agency: DOJ
Specific Documents Requested: The correspondence between the DOJ and the drug manufacturers. Specifically the initial inquiries and any follow-up correspondence.
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.